Search - tctmd.com

Displaying 321 - 340 of 1451

Sort: Relevancy | Date

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News ACC 2024

ADHD Meds Linked to Cardiomyopathy in Young Adults

Todd Neale

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

L.A. McKeown

March 27, 2024

News Daily News

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Todd Neale

March 25, 2024

News Daily News

Internists in HF: A Solution to a Lack of Care?

Yael L. Maxwell

March 19, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

3D-Bioprinted Human Tissue and the Path Towards Clinical Translation

Presenter: Adam W. Feinberg

March 06, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Presentation THT 2024

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Presenter: Kamile Cerlinskaite-Bajore

March 06, 2024

Presentation THT 2024

Multicenter Development and Validation of a Supervised Machine Learning Risk Model to Predict Right Ventricular Failure Following Mechanical Circulatory Support: The STOP-RVF Score

Presenter: Stavros G. Drakos

March 06, 2024

Presentation THT 2024

AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial

Presenter: Deya Alkhatib

March 06, 2024

Advertisement

April 2024 Dispatch for the CV Team

ADHD Meds Linked to Cardiomyopathy in Young Adults

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Biologic Winrevair Wins FDA Approval for Treatment of PAH

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Internists in HF: A Solution to a Lack of Care?

Cognitive Impairment a Real Concern in HF Patients: HFSA

Physicians (Mostly) Negative on Private Equity in Healthcare

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

3D-Bioprinted Human Tissue and the Path Towards Clinical Translation

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Semaglutide Winning Streak Continues in CKD With FLOW

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Multicenter Development and Validation of a Supervised Machine Learning Risk Model to Predict Right Ventricular Failure Following Mechanical Circulatory Support: The STOP-RVF Score

AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content